Research
Hormonal
Intermittent fasting improves glycemic control in patients with Type 2 Diabetes, including reductions in fasting glucose, HbA1c, and insulin levels, though it carries a risk of hypoglycemia requiring medication adjustment.
If you have Type 2 Diabetes, intermittent fasting can improve your blood sugar control, but you must work with your doctor to adjust medications like insulin or sulfonylureas to avoid low blood sugar. Studies show that with proper management, IF is safe and can lower HbA1c and fasting glucose levels without severe adverse events.
ModerateQualifiesMEDIUM confidence
The 5 studies that included patients with type 2 diabetes documented improved glycemic control... Use of IF in patients with diabetes poses a risk of hypoglycemia. Olansky suggests adjusting medication in patients with type 2 diabetes taking insulin or insulin secretagogues.
Why this rating
Based on 5 small RCTs (Level I/II) in diabetic patients.
Source
Intermittent fasting and weight loss: Systematic review.
Stephanie Welton et al. · PubMed · 2020
systematic_review · n=944Cited 211×
Read the paper Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →